Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Querétaro, México.
Nutr J. 2010 Sep 23;9:40. doi: 10.1186/1475-2891-9-40.
Anemia continues to be a major public health problem among children in many regions of the world, and it is still not clear which strategy to treat it is most effective.
To evaluate the efficacy and children's acceptance of several recognized strategies to treat anemia.
Non-breastfed children (n = 577), 6 to 43 mo of age, were screened for the trial; 267 were anemic (hemoglobin < 11.7 g/dL), and 266 of those were randomized into 1 of 5 treatments to received daily either: an iron supplement (IS), an iron+folic acid supplement (IFS), a multiple micronutrient supplement (MMS), a micronutrient-fortified complementary food as porridge powder (FCF), or zinc+iron+ascorbic acid fortified water (FW). The iron content of each daily dose was 20, 12.5, 10, 10 and 6.7 mg respectively. Hemoglobin (Hb), ferritin, total iron, weight and height were measured at baseline and after 4 months of treatment. Morbidity, treatment acceptability and adherence were recorded during the intervention.
All treatments significantly increased Hb and total iron concentration; ferritin did not change significantly. Groups MMS, IS and IFS increased Hb (g/dL) [1.50 (95%CI: 1.17, 1.83), 1.48 [(1.18, 1.78) and 1.57 (1.26, 1.88), respectively] and total iron ((μg/dL) [0.15 (0.01, 0.29), 0.19 (0.06, 0.31) and 0.12(-0.01, 0.25), respectively] significantly more than FCF [0.92 (0.64, 1.20)] but not to FW group [0.14 (0.04, 0.24)]. The prevalence of anemia was reduced to a greater extent in the MMS and IFS groups (72% and 69%, respectively) than in the FCF group (45%) (p < 0.05). There were no significant differences in anthropometry or in the number of episodes of diarrhea and respiratory infections among treatment groups. The supplements MMS and IS were less acceptable to children, than IFS, FCF and FW.
The three supplements IS, ISF and MMS increased Hb more than the FCF; the supplements that contained micronutrients (IFS and MMS) were more effective for reducing the prevalence of anemia. In general, fortified foods were better accepted by the study participants than supplements. CLINICALTRIAL.GOV IDENTIFIER: NCT00822380.
贫血仍是世界上许多地区儿童面临的主要公共卫生问题,但仍不清楚哪种治疗策略最有效。
评估几种公认的治疗贫血策略的疗效和儿童接受程度。
筛选出 6 至 43 月龄、非母乳喂养的儿童(n=577)参与试验;其中 267 名儿童患有贫血(血红蛋白 < 11.7 g/dL),其中 266 名随机分为 5 种治疗组之一,每天接受以下治疗:铁补充剂(IS)、铁+叶酸补充剂(IFS)、多种微量营养素补充剂(MMS)、强化微量营养素的补充食品(FCF)或锌+铁+抗坏血酸强化水(FW)。每日剂量的铁含量分别为 20、12.5、10、10 和 6.7 mg。在基线和治疗 4 个月后测量血红蛋白(Hb)、铁蛋白、总铁、体重和身高。在干预过程中记录发病率、治疗接受度和依从性。
所有治疗均显著增加 Hb 和总铁浓度;铁蛋白无显著变化。MMS、IS 和 IFS 组增加 Hb(g/dL)[1.50(95%CI:1.17,1.83)、1.48(1.18,1.78)和 1.57(1.26,1.88)]和总铁(μg/dL)[0.15(0.01,0.29)、0.19(0.06,0.31)和 0.12(-0.01,0.25)]显著多于 FCF 组[0.92(0.64,1.20)],但不如 FW 组[0.14(0.04,0.24)]。MMS 和 IFS 组贫血患病率降低幅度明显大于 FCF 组(72%和 69%,分别)(p < 0.05)。各组间人体测量或腹泻和呼吸道感染次数无显著差异。MMS 和 IS 两种补充剂的儿童接受程度低于 IFS、FCF 和 FW。
三种补充剂 IS、ISF 和 MMS 增加 Hb 的效果优于 FCF;含微量营养素的补充剂(IFS 和 MMS)对降低贫血患病率更有效。一般来说,强化食品比补充剂更受研究参与者的欢迎。临床试验注册编号:NCT00822380。